Growth Metrics

Beta Bionics (BBNX) Cash from Investing Activities (2024 - 2026)

Beta Bionics' Cash from Investing Activities history spans 3 years, with the latest figure at $21.8 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 112.19% to $21.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $38.2 million, a 120.06% increase, with the full-year FY2025 number at -$162.8 million, down 4583.69% from a year prior.
  • Cash from Investing Activities hit $21.8 million in Q1 2026 for Beta Bionics, up from $658000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for BBNX hit a ceiling of $21.8 million in Q1 2026 and a floor of -$179.1 million in Q1 2025.
  • Historically, Cash from Investing Activities has averaged -$16.0 million across 3 years, with a median of $6.2 million in 2025.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 2443.3% in 2025 and later skyrocketed 112.19% in 2026.
  • Tracing BBNX's Cash from Investing Activities over 3 years: stood at -$29.7 million in 2024, then soared by 102.22% to $658000.0 in 2025, then surged by 3219.0% to $21.8 million in 2026.
  • Business Quant data shows Cash from Investing Activities for BBNX at $21.8 million in Q1 2026, $658000.0 in Q4 2025, and $9.5 million in Q3 2025.